Search results
Mar 6, 2018 · Pharma distributor's son Satish Mehta founded and runs privately held generics maker Emcure Pharmaceuticals. He started Emcure in Pune city as a contract manufacturer for multinationals in 1981...
Satish Mehta is the first-generation entrepreneur and visionary who started Emcure in 1981 with the purpose to provide affordable and high quality healthcare to patients to significantly improve their lives.
Oct 4, 2017 · About Satish Mehta & family. Pharma distributor's son Satish Mehta founded and runs Emcure Pharmaceuticals, which has private equity firm Bain Capital as an investor. Mehta started the...
Samit Satish Mehta Whole-time Director. Palamadai Sundararajan Jayakumar Independent Director. Samonnoi Banerjee Non Executive Director. Shailesh Kripalu Ayyangar Independent Director. Vijay Keshav Gokhale Independent Director. Vidya Rajiv Yeravdekar Independent Director. Senior Management Balaji Aravamuthan President IT and Digital. Rajesh Nair President – HR.
Aug 19, 2021 · Second-generation entrepreneur Satish Mehta started Emcure Pharmaceuticals decades before ‘Made in India’ or ‘Build in India’ became catchphrases.
Satish Mehta, MD & CEO of Emcure Pharmaceuticals is having his moment under the sun. Emcure’s subsidiary, Gennova, is working on India’s first indigenously developed mRNA COVID-19 vaccine. Phase-2 and Phase-3 trials are currently underway.
Feb 1, 2024 · Satish Ranamnlal Mehta is the founder of Emcure pharmaceuticals and also serves as the CEO and Managing Director of the company. He is a postgraduate in Chemistry from Pune University and has a diploma in management from the IIM, Ahmedabad.
Aug 9, 2021 · Satish Mehta, founder and CEO of Emcure Pharmaceuticals, says that while he is satisfied with the primary outcome on safety of the vaccine, he will soon submit the data with CDSCO and apply for next phase trials.
Jul 27, 2021 · Established in 1981, the firm was founded by Mr. Satish Mehta who spotted an opportunity in contract manufacturing pharmaceuticals for MNCs. Emcure is ranked as the 12 th largest pharma company in India (AIOCD-AWACS MAT Mar 21).
3 days ago · Promoters Satish Ramanlal Mehta, Sunil Rajanikant Mehta, Namita Vikas Thapar, and Samit Satish Mehta are the selling shareholders in the OFS. In addition, Pushpa Rajnikant Mehta, Bhavana Satish ...
